Approximately 51% of primary hip and knee joint replacement surgeries will be performed in an outpatient setting by 2026—up from just 15% in 2016.
Get ready for more procedures moving to outpatient settings, larger provider entities and market consolidation.
Modern Healthcare’s annual list of the 100 most influential people in health care is out, and Vizient CEO Byron Jobe lands at No. 66.
Vizient and Sg2 are very proud to be named, for the second consecutive year, as one of Modern Healthcare’s 150 Best Places to Work in Healthcare for 2018.
Consumers are listening, particularly when it comes to elective procedures such as joint replacement.
According to Sg2’s forecast, outpatient surgery is expected to see an overall 11% increase from 2017 to 2022.
